{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:54:08Z","timestamp":1777870448797,"version":"3.51.4"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"DOI":"10.1007\/s40620-024-02034-2","type":"journal-article","created":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T05:03:55Z","timestamp":1722229435000},"page":"1731-1735","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Two cases of typical HUS in adults treated with an anti-C5 monoclonal antibody: a new perspective?"],"prefix":"10.1093","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3701-7004","authenticated-orcid":false,"given":"Emelina","family":"Stambolliu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiota","family":"Giannou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efrossyni","family":"Nomikou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Aggelis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Petras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,7,29]]},"reference":[{"key":"2034_CR1","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1136\/archdischild-2016-311377","volume":"103","author":"PR Walsh","year":"2018","unstructured":"Walsh PR, Johnson S (2018) Treatment and management of children with haemolytic uraemic syndrome. Arch Dis Child 103:285\u2013291. https:\/\/doi.org\/10.1136\/archdischild-2016-311377. (Epub 2017 Sep 12)","journal-title":"Arch Dis Child"},{"issue":"9","key":"2034_CR2","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1007\/s00467-020-04560-0","volume":"35","author":"E Ylinen","year":"2020","unstructured":"Ylinen E, Salmenlinna S, Halkilahti J, Jahnukainen T, Korhonen L, Virkkala T et al (2020) Hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli in children: incidence, risk factors, and clinical outcome. Pediatr Nephrol 35(9):1749\u20131759. https:\/\/doi.org\/10.1007\/s00467-020-04560-0. (Epub 2020 Apr 22)","journal-title":"Pediatr Nephrol"},{"issue":"11","key":"2034_CR3","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1007\/s00467-010-1522-1","volume":"25","author":"C Zoja","year":"2010","unstructured":"Zoja C, Buelli S, Morigi M (2010) Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction. Pediatr Nephrol 25(11):2231\u20132240. https:\/\/doi.org\/10.1007\/s00467-010-1522-1. (Epub 2010 Apr 28)","journal-title":"Pediatr Nephrol"},{"key":"2034_CR4","first-page":"99","volume":"11","author":"R Habib","year":"1982","unstructured":"Habib R, Levy M, Gagnadoux M et al (1982) Prognosis of the hemolytic uremic syndrome in children. Adv Nephrol Necker Hosp 11:99","journal-title":"Adv Nephrol Necker Hosp"},{"issue":"7","key":"2034_CR5","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.2215\/CJN.08921209","volume":"5","author":"S Nathanson","year":"2010","unstructured":"Nathanson S, Kwon T, Elmaleh M et al (2010) Acute neurological involvement in diarrhea-associated hemolytic uremic syndrome. Clin J Am Soc Nephrol 5(7):1218. https:\/\/doi.org\/10.2215\/CJN.08921209. (Epub 2010 May 24)","journal-title":"Clin J Am Soc Nephrol"},{"key":"2034_CR6","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1007\/s00467-012-2383-6","volume":"28","author":"JM Spinale","year":"2013","unstructured":"Spinale JM, Ruebner RL, Copelovitch L, Kaplan BS (2013) Long-term outcomes of Shiga toxin hemolytic uremic syndrome. Pediatr Nephrol 28:2097\u20132105. https:\/\/doi.org\/10.1007\/s00467-012-2383-6. (Epub 2013 Jan 4)","journal-title":"Pediatr Nephrol"},{"issue":"9796","key":"2034_CR7","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/S0140-6736(11)61145-8","volume":"378","author":"E Colic","year":"2011","unstructured":"Colic E, Dieperink H, Titlestad K, Tepel M (2011) Management of an acute outbreak of diarrhoea-associated haemolytic uraemic syndrome with early plasma exchange in adults from southern Denmark: an observational study. Lancet 378(9796):1089. https:\/\/doi.org\/10.1016\/S0140-6736(11)61145-8. (Epub 2011 Aug 24)","journal-title":"Lancet"},{"issue":"6","key":"2034_CR8","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1056\/NEJM199508103330608","volume":"333","author":"TG Boyce","year":"1995","unstructured":"Boyce TG, Swerdlow DL, Griffin PM (1995) Escherichia coli O157:H7 and the hemolytic-uremic syndrome. N Engl J Med 333(6):364","journal-title":"N Engl J Med"},{"issue":"1","key":"2034_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/microorganisms7010015","volume":"7","author":"S Buelli","year":"2019","unstructured":"Buelli S, Zoja C, Remuzzi G, Morigi M (2019) Complement Activation Contributes to the Pathophysiology of Shiga toxin-associated hemolytic uremic syndrome. Microorganisms 7(1):15. https:\/\/doi.org\/10.3390\/microorganisms7010015","journal-title":"Microorganisms"},{"issue":"10","key":"2034_CR10","doi-asserted-by":"publisher","first-page":"6394","DOI":"10.4049\/jimmunol.0900151","volume":"182","author":"D Orth","year":"2009","unstructured":"Orth D, Khan AB, Naim A et al (2009) Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome. J Immunol 182(10):6394\u20136400. https:\/\/doi.org\/10.4049\/jimmunol.0900151","journal-title":"J Immunol"},{"issue":"9","key":"2034_CR11","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1681\/ASN.0000000000000182","volume":"34","author":"A Garnier","year":"2023","unstructured":"Garnier A, Brochard K, Kwon T et al (2023) Efficacy and safety of eculizumab in pediatric patients affected by Shiga toxin-related hemolytic and uremic syndrome: a randomized, placebo-controlled trial. J Am Soc Nephrol 34(9):1561\u20131573. https:\/\/doi.org\/10.1681\/ASN.0000000000000182. (Epub 2023 Jun 12)","journal-title":"J Am Soc Nephrol"},{"key":"2034_CR12","doi-asserted-by":"publisher","unstructured":"ISRCTN Registry (2016) A study of the benefit of a medicine called eculizumab in Shiga-toxin producing E. coli haemolytic syndrome. https:\/\/doi.org\/10.1186\/ISRCTN89553116","DOI":"10.1186\/ISRCTN89553116"},{"issue":"10","key":"2034_CR13","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1093\/ndt\/gfs394","volume":"27","author":"JT Kielstein","year":"2012","unstructured":"Kielstein JT, Beutel G, Fleig S et al (2012) Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registry. Nephrol Dial Transplant 27(10):3807\u20133815. https:\/\/doi.org\/10.1093\/ndt\/gfs394","journal-title":"Nephrol Dial Transplant"},{"key":"2034_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e4565","volume":"345","author":"J Menne","year":"2012","unstructured":"Menne J, Nitschke M, Stingele R et al (2012) Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study. BMJ 345:e4565. https:\/\/doi.org\/10.1136\/bmj.e4565","journal-title":"BMJ"},{"issue":"3","key":"2034_CR15","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/ndt\/gft470","volume":"29","author":"Y Delmas","year":"2014","unstructured":"Delmas Y, Vendrely B, Clouzeau B et al (2014) Outbreak of Escherichia coli O104:H4 haemolytic uraemic syndrome in France: outcome with eculizumab. Nephrol Dial Transplant 29(3):565\u2013572. https:\/\/doi.org\/10.1093\/ndt\/gft470. (Epub 2013 Nov 28)","journal-title":"Nephrol Dial Transplant"},{"issue":"357","key":"2034_CR16","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.3389\/fmed.2020.00357.eCollection","volume":"7","author":"GS Netti","year":"2020","unstructured":"Netti GS, Santangelo L, Paulucci L et al (2020) Low C3 serum levels predict severe forms of STEC-HUS with neurologic involvement. Front Med (Lausanne) 7(357):2020. https:\/\/doi.org\/10.3389\/fmed.2020.00357.eCollection","journal-title":"Front Med (Lausanne)"},{"issue":"12","key":"2034_CR17","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1002\/ccr3.3221","volume":"8","author":"BE Nelson","year":"2020","unstructured":"Nelson BE, Hong A, Iqbal F, Jana B (2020) A unique case of hemolytic-uremic syndrome secondary to enteropathogenic E Coli. Clin Case Rep 8(12):2625\u20132628. https:\/\/doi.org\/10.1002\/ccr3.3221. (eCollection 2020 Dec)","journal-title":"Clin Case Rep"},{"key":"2034_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055278","volume":"8","author":"S Ullrich","year":"2013","unstructured":"Ullrich S, Bremer P, Neumann-Grutzeck C et al (2013) Symptoms and clinical course of EHEC O104 infection in hospitalized patients: a prospective single center study. PLoS\u00a0One 8:e55278. https:\/\/doi.org\/10.1371\/journal.pone.0055278. (Epub 2013 Feb 27)","journal-title":"PLoS\u00a0One"},{"key":"2034_CR19","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.3201\/eid2707.204638","volume":"27","author":"B Travert","year":"2021","unstructured":"Travert B, Dossier A, Jamme M et al (2021) Shiga toxin-associated hemolytic uremic syndrome in adults, France, 2009\u20132017. Emerg Infect Dis 27:1876\u20131885. https:\/\/doi.org\/10.3201\/eid2707.204638","journal-title":"Emerg Infect Dis"},{"key":"2034_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-023-06216-1","author":"PL de Zwart","year":"2023","unstructured":"de Zwart PL, Mueller TF, Spart\u00e0 G, Luyckx VA (2023) Eculizumab in Shiga toxin-producing Escherichia coli hemolytic uremic syndrome: a systematic review. Pediatr Nephrol (ahead of print). https:\/\/doi.org\/10.1007\/s00467-023-06216-1","journal-title":"Pediatr Nephrol (ahead of print)"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-024-02034-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-024-02034-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-024-02034-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:59:37Z","timestamp":1777564777000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/38\/6\/1731\/8461051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,29]]},"references-count":20,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["2034"],"URL":"https:\/\/doi.org\/10.1007\/s40620-024-02034-2","relation":{},"ISSN":["1724-6059"],"issn-type":[{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,29]]},"assertion":[{"value":"12 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval for reporting individual cases or case series\u00a0is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"In reporting these cases, written informed consent was obtained from the patients.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}